Fig. 6: Forest plot of Prosigna-trained test results re-stratified by other tests, Node-ve ER+ve/HER2-ve cases treated without chemotherapy. | npj Breast Cancer

Fig. 6: Forest plot of Prosigna-trained test results re-stratified by other tests, Node-ve ER+ve/HER2-ve cases treated without chemotherapy.

From: Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study

Fig. 6

DMFS10 = distant metastasis free survival at 10 years post diagnosis. (95% CI) = 95% confidence interval, P = p value, N = number of cases in each subgroup, % = percentage of cases within each risk strata, X axis = percent distant metastasis free survival. Open boxes represent primary test DMFS10 by risk group. Solid boxes represent sub-stratification by secondary tests with 95% confidence intervals (bars). Top panel (a) Prosigna-trained low-risk cases stratified by Oncotype-trained and Mammaprint-trained results. Middle panel (b) Prosigna-trained moderate risk group. Bottom panel (c) Prosigna-trained high risk group.

Back to article page